MESOMARK test for mesothelioma patients now available to doctors in the U.S.

27

Mar
2007

The MESOMARK Assay, a blood test developed to monitor patients with mesothelioma–a form of cancer caused by asbestos exposure–is now available to physicians in the U.S.. The test, which can be used to help manage the care of patients with epitheloid or biphasic mesothelioma, requires only a blood sample to be taken from the patient. The MESOMARK was recently approved by the U.S. Food and Drug Administration (FDA) under the agency’s Humanitarian Device Exemption (HDE) program. Mesothelioma is a form of cancer mainly affecting people exposed to asbestos in the workplace.

email this page print this page permanent link

Related News

Baron & Budd, P.C.:
Since 1977, the law firm of Baron & Budd, P.C. has championed the rights of people and communities harmed by corporate misconduct. With over 50 attorneys and offices in Texas, California, and Louisiana, Baron & Budd enjoys a national reputation as a leader of the plaintiffs’ bar. The firm represents individuals with mesothelioma and other diseases caused by asbestos and injuries caused by other toxic substances and pharmaceuticals. The firm also represents water authorities seeking clean-up costs for drinking water contamination; securities investors and governmental entities defrauded by corporate wrongdoing; and consumers. For more information about Baron & Budd, call 800-222-2766 or contact us via our secure form.

 
Other Offices:
  • Baton Rouge, LA
  • Cleveland, OH
  • Beverly Hills, CA
  • Austin, TX
Main Office:
3102 Oak Lawn Avenue, Suite 1100
Dallas, TX 75219
For nearly 30 years, the law firm of Baron & Budd, P.C. has fought to safeguard the rights of mesothelioma victims and their families. MesotheliomaNews.com is a public service of Baron & Budd, P.C.

© 2008, Baron & Budd, P.C.